Contract 75F40124C00106
The Critical Path Institute · Department Of Health And Human Services · August 16, 2024
The Critical Path Institute was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on August 16, 2024 for $1.85 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Tucson, AZ. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 22, 2025. If all options are exercised, the contract could reach $3.38 million.
Contract details
- PIID
- 75F40124C00106
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Tucson, AZ
- First action
- August 16, 2024
- Latest action
- August 22, 2025
Description
BAA FOR DEVELOPMENT OF DRUG DEVELOPMENT TOOLS FOR ADTKD
Modification timeline
-
August 22, 2025Mod P00004 · Other Administrative Action$1.85M
-
July 15, 2025Mod P00003 · Exercise An Option$1.85M
-
August 16, 2024Base award$951.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40124C00106?
Contract 75F40124C00106 is a federal contract awarded to The Critical Path Institute by Department Of Health And Human Services on August 16, 2024 for $1.85 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75F40124C00106?
The Critical Path Institute won contract 75F40124C00106 from Department Of Health And Human Services.
How much is contract 75F40124C00106 worth?
Contract 75F40124C00106 has obligated $1.85 million to date, with a total potential value of $3.38 million if all options are exercised.